Page last updated: 2024-08-24

irinotecan and Meningioma

irinotecan has been researched along with Meningioma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chamberlain, MC; Groshen, S; Tsao-Wei, DD1
Chamberlain, MC; Chen, TC; Gupta, V; Hofman, FM; Liebes, LF; Samuelson, CG; Schönthal, AH; Su, YS1

Trials

1 trial(s) available for irinotecan and Meningioma

ArticleYear
Salvage chemotherapy with CPT-11 for recurrent meningioma.
    Journal of neuro-oncology, 2006, Volume: 78, Issue:3

    Topics: Aged; Agranulocytosis; Anticonvulsants; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Camptothecin; Diarrhea; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Irinotecan; Leukopenia; Male; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Treatment Failure

2006

Other Studies

1 other study(ies) available for irinotecan and Meningioma

ArticleYear
Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas.
    Journal of neurosurgery, 2007, Volume: 106, Issue:3

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Cell Culture Techniques; Cell Line, Tumor; Disease Models, Animal; Irinotecan; Male; Meningioma; Mice; Mice, Nude; Proto-Oncogene Proteins c-bcl-2; Soft Tissue Neoplasms; Subcutaneous Tissue

2007